Intensity TherapeuticsINTS
13F holders, Q1 2024 (March 31)18holders
$5.20avg. 13F price*
At the end of Q1 2024, 18 institutions reported holding Intensity Therapeutics Inc. (INTS) in their 13F filings. The largest holders were Sapient Capital LLC ($5.3M), Vanguard Group Inc. ($921K) and Brown Advisory Inc. ($819K).
- Company
- Intensity Therapeutics Inc.
- CUSIP
- 45828J103
- Latest filing quarter
- Q4 2025
History
Number of 13F holders
Total Exit/New Position Q1 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 5 | $1.2M |
| Exits | 5 | $693K |
Ownership 18 holders
| Sapient Capital LLC | 0.12% | Add +406.0% | 1,012,069 | $5.3M |
| Vanguard Group Inc. | 0.00% | Add +113.3% | 177,187 | $921K |
| Brown Advisory Inc. | 0.00% | New | 157,526 | $819K |
| Sigma Planning Corp | 0.01% | Add +39.0% | 47,869 | $249K |
| Geode Capital Management, LLC | 0.00% | Add +5.0% | 47,620 | $248K |
| Mesirow Financial Investment Management, Inc. | 0.01% | Add +29.3% | 44,177 | $230K |
| One Charles Private Wealth Services, LLC | 0.07% | New | 31,800 | $165K |
| Rothschild Wealth LLC | 0.05% | — | 28,812 | $150K |
| Bison Wealth, LLC | 0.01% | New | 17,420 | $91K |
| State Street Corp. | 0.00% | No change | 14,500 | $75K |
| Qube Research & Technologies Ltd | 0.00% | Add +80.0% | 11,095 | $58K |
| BlackRock Inc. | 0.00% | Reduce -2.4% | 10,724 | $56K |
| Commonwealth Equity Services, LLC | 0.00% | New | 10,414 | $54K |
| JPMorgan Chase & Co. | 0.00% | Add +22072.5% | 8,869 | $46K |
| Tower Research Capital LLC (TRC) | 0.00% | New | 7,033 | $37K |
| UBS Group AG | 0.00% | Add +502.2% | 3,011 | $16K |
| Wells Fargo & Company | 0.00% | Add +0.0% | 2,482 | $13K |
| Royal Bank of Canada | 0.00% | Reduce -69.6% | 7 | $0 |
"% of holder's portfolio" is INTS's weight in each manager's 13F, not the share of Intensity Therapeutics Inc. the manager owns.